Pignata, Laura
Cecere, Francesco
Verma, Ankit
Hay Mele, Bruno
Monticelli, Maria
Acurzio, Basilia
Giaccari, Carlo
Sparago, Angela
Hernandez Mora, Jose Ramon
Monteagudo-Sánchez, Ana
Esteller, Manel
Pereda, Arrate
Tenorio-Castano, Jair
Palumbo, Orazio
Carella, Massimo
Prontera, Paolo
Piscopo, Carmelo
Accadia, Maria
Lapunzina, Pablo
Cubellis, Maria Vittoria
de Nanclares, Guiomar Perez
Monk, David
Riccio, Andrea
Cerrato, Flavia http://orcid.org/0000-0003-3794-3021
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (665403, 665403)
Associazione Italiana per la Ricerca sul Cancro (24405)
Università degli Studi della Campania Luigi Vanvitelli (Valere-MIRIAM, Valere-MIRIAM, Valere-MIRIAM)
Regione Campania (I-Cure, I-Cure)
Instituto de Salud Carlos III (PI20/00950, Instituto de Salud Carlos III)
European Regional Development Fund (2019 research unit grant from ESPE)
Article History
Received: 8 February 2022
Accepted: 16 May 2022
First Online: 28 May 2022
Declarations
:
: Written informed consent to genetic analyses was obtained from the patients or their parents. The ethical principles and the Italian and Spanish legislation were applied in all steps of the research work that was approved by the Ethical Committees of the University of Campania “Luigi Vanvitelli” (approval number: 1135), the Hospital Universitario La Paz (CEIm, PI-659) and the Clinica del Hospital Universitari de Bellvitge (PR096/10), and the Basque Clinical Research Ethics Committee (CEIC-E, PI2017018).
: Consent for publication of clinical and molecular data were obtained from all participants involved in this study.
: The authors declare that they have no potential competing interests to disclose. The authors declare that they have no financial relationships relevant to this article to disclose.